Brady W. Dougan, Director, 10% Owner at Humacyte, Inc. (HUMA), sold 1,069,460 shares at $2.84 ($3.0M) on 2022-12-13, disclosed to the SEC on 2022-12-15.
Open-market sale of $3.0M HUMA by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.84 | 330,000 | $937K | 31.7% |
| 2 | $2.76 | 276,304 | $763K | 25.8% |
| 3 | $2.76 | 276,304 | $763K | 25.8% |
| 4 | $2.63 | 93,426 | $246K | 8.3% |
| 5 | $2.63 | 93,426 | $246K | 8.3% |
| Total | $2.76 avg | 1,069,460 |
| $3.0M |
| 100% |
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |